Cytovale is a commercial-stage medical diagnostics company specializing in the development of early detection technologies for fast-moving and immune-mediated diseases. Their flagship product, the FDA-cleared IntelliSep test, provides rapid sepsis detection, helping hospitals enhance patient care and reduce costs. The company is focused on expanding the availability of this technology to emergency departments across the United States.
Leadership & Board
Current Number of Employees124
Current LinkedIn Followers17,000
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$100M
Total Amount Raised$100M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$100M
Latest Funding Amount$100M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation―
Post-Money Valuation―
Company Momentum Positive
Articles Published on TipRanks1
Articles Published on TipRanks
1
LinkedIn Trend+0.29% followers
LinkedIn Trend
+0.29% followers
Workforce Trend+0.8% employees
Workforce Trend
+0.8% employees
Cytovale LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.
Employee Trend
Cytovale had 124 employees as of September 14, 2026. The number of employees increased by 1 (0.81%) week-over-week.
124Latest Employee Count
1(0.81%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Cytovale had 17,000 followers as of September 14, 2026. The number of followers increased by 49 (0.29%) week-over-week.
17,000Latest Followers Count
49(0.29%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Aug 14, 2025
Series D
$100.00M
―
Investors
Series D
Series D
Series D
Similar Companies
A snapshot of private companies similar to Cytovale, helping you discover and navigate related company profiles.
